Anisa Shaker

1.4k total citations
31 papers, 1.1k citations indexed

About

Anisa Shaker is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anisa Shaker has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 12 papers in Gastroenterology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anisa Shaker's work include Gastroesophageal reflux and treatments (12 papers), Esophageal and GI Pathology (11 papers) and Esophageal Cancer Research and Treatment (6 papers). Anisa Shaker is often cited by papers focused on Gastroesophageal reflux and treatments (12 papers), Esophageal and GI Pathology (11 papers) and Esophageal Cancer Research and Treatment (6 papers). Anisa Shaker collaborates with scholars based in United States, United Kingdom and China. Anisa Shaker's co-authors include Deborah C. Rubin, Marc S. Levin, Vladimir Kushnir, Jesse Drapekin, Nathaniel Stoikes, Matthew A. Ciorba, Ameet I. Thaker, Mahil Rao, Prakash C. Gyawali and Michael L. Brunt and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Anisa Shaker

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anisa Shaker United States 11 445 337 319 201 170 31 1.1k
Motonari Nomura Japan 14 194 0.4× 368 1.1× 41 0.1× 152 0.8× 118 0.7× 56 819
Katsuaki Kato Japan 24 843 1.9× 276 0.8× 340 1.1× 130 0.6× 253 1.5× 74 1.4k
Eun Ae Kang South Korea 18 201 0.5× 248 0.7× 46 0.1× 122 0.6× 81 0.5× 51 842
Brooks Scull United States 16 272 0.6× 595 1.8× 64 0.2× 222 1.1× 256 1.5× 28 1.3k
Goo Lee United States 15 223 0.5× 280 0.8× 35 0.1× 210 1.0× 190 1.1× 53 861
Juan Qian China 21 193 0.4× 344 1.0× 75 0.2× 183 0.9× 304 1.8× 33 1.0k
Keisho Kataoka Japan 15 508 1.1× 205 0.6× 65 0.2× 284 1.4× 162 1.0× 54 959
Martin Raithel Germany 24 587 1.3× 374 1.1× 302 0.9× 131 0.7× 607 3.6× 126 1.7k
Yongjia Feng United States 20 315 0.7× 333 1.0× 47 0.1× 119 0.6× 127 0.7× 31 1.0k
Navdha Mittal United States 8 154 0.3× 256 0.8× 55 0.2× 65 0.3× 122 0.7× 9 569

Countries citing papers authored by Anisa Shaker

Since Specialization
Citations

This map shows the geographic impact of Anisa Shaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anisa Shaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anisa Shaker more than expected).

Fields of papers citing papers by Anisa Shaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anisa Shaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anisa Shaker. The network helps show where Anisa Shaker may publish in the future.

Co-authorship network of co-authors of Anisa Shaker

This figure shows the co-authorship network connecting the top 25 collaborators of Anisa Shaker. A scholar is included among the top collaborators of Anisa Shaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anisa Shaker. Anisa Shaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shaker, Anisa & Edy Soffer. (2025). Gastroesophageal reflux disease related to laparoscopic sleeve gastrectomy. Mini-invasive Surgery. 9.
3.
Shaker, Anisa. (2025). Physiologic and molecular effects of alcohol in the esophagus: a narrative review. PubMed. 8. 10–10. 1 indexed citations
4.
Shaker, Anisa. (2024). Esophageal remodeling in eosinophilic esophagitis. Current Opinion in Gastroenterology. 40(4). 291–298. 1 indexed citations
5.
Li, Tao, et al.. (2023). Direct and indirect effects of alcohol and its toxic metabolite acetaldehyde on human esophageal myofibroblasts and epithelial cells. Alcohol Clinical and Experimental Research. 47(7). 1297–1311. 2 indexed citations
6.
Li, Meng, et al.. (2022). Inflammatory and Proliferative Pathway Activation in Human Esophageal Myofibroblasts Treated with Acidic Bile Salts. International Journal of Molecular Sciences. 23(18). 10371–10371. 8 indexed citations
7.
Shaker, Anisa, et al.. (2021). Pattern of methane levels with lactulose breath testing; can we shorten the test duration?. JGH Open. 5(7). 809–812. 7 indexed citations
8.
Hu, Liping, Chunying Zhang, Kevin Yang, Meng Li, & Anisa Shaker. (2020). Human esophageal myofibroblasts increase squamous epithelial thickness via paracrine mechanisms in an in vitro model of gastroesophageal reflux disease. PLoS ONE. 15(9). e0238852–e0238852. 4 indexed citations
9.
Zhang, Chunying, Chao Niu, Kevin Yang, & Anisa Shaker. (2018). Human esophageal myofibroblast secretion of bone morphogenetic proteins and GREMLIN1 and paracrine regulation of squamous epithelial growth. Scientific Reports. 8(1). 12354–12354. 9 indexed citations
10.
Niu, Chao, et al.. (2016). Generation and Characterization of an Immortalized Human Esophageal Myofibroblast Line. PLoS ONE. 11(4). e0153185–e0153185. 4 indexed citations
11.
Farmer, Adam D., et al.. (2016). Provocative testing of the esophagus and its future. Annals of the New York Academy of Sciences. 1380(1). 33–47. 5 indexed citations
12.
Gargus, Matthew, Chao Niu, & Anisa Shaker. (2015). Isolation of Myofibroblasts from Mouse and Human Esophagus. Journal of Visualized Experiments. 52215–52215. 7 indexed citations
13.
Shaker, Anisa, Matthew Gargus, Jana Binkley, et al.. (2014). Epimorphin−/− mice are protected, in part, from acute colitis via decreased interleukin 6 signaling. Translational research. 164(1). 70–83. 6 indexed citations
14.
Shaker, Anisa, Nathaniel Stoikes, Jesse Drapekin, et al.. (2013). Multiple Rapid Swallow Responses During Esophageal High-Resolution Manometry Reflect Esophageal Body Peristaltic Reserve. The American Journal of Gastroenterology. 108(11). 1706–1712. 190 indexed citations
15.
Thaker, Ameet I., Anisa Shaker, Mahil Rao, & Matthew A. Ciorba. (2012). Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS). Journal of Visualized Experiments. 138 indexed citations
16.
Rubin, Deborah C., Anisa Shaker, & Marc S. Levin. (2012). Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Frontiers in Immunology. 3. 107–107. 306 indexed citations
17.
Kerr, Thomas A., Matthew A. Ciorba, Hitoshi Matsumoto, et al.. (2011). Dextran Sodium Sulfate Inhibition of Real-Time Polymerase Chain Reaction Amplification: A Poly-A Purification Solution. Inflammatory Bowel Diseases. 18(2). 344–348. 44 indexed citations
18.
Shaker, Anisa, Elzbieta A. Swietlicki, Lihua Wang, et al.. (2010). Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion. Journal of Clinical Investigation. 120(6). 2081–2093. 47 indexed citations
19.
Shaker, Anisa & Deborah C. Rubin. (2010). Intestinal stem cells and epithelial–mesenchymal interactions in the crypt and stem cell niche. Translational research. 156(3). 180–187. 76 indexed citations
20.
Kendra, Kari, Jacek Gan, Jean E. Surfus, et al.. (1999). Pharmacokinetics and stability of the ch14.18-interleukin-2 fusion protein in mice. Cancer Immunology Immunotherapy. 48(5). 219–229. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026